GlaxoSmithKline

EU commissioner widens pharma probe

admin — Thu, 15 May 2008 06:59:55 -0400

Europe's competition commissioner is casting a wide net in her pharma-market antitrust probe. After questioning some 100 companies--including Pfizer, GlaxoSmithKline, and Read more...

Did GSK ignore early abacavir warning?

admin — Mon, 12 May 2008 06:59:55 -0400

Back in 2005, Swedish pharma monitors raised a red flag on the HIV fighter abacavir and its possible link to heart attacks, The Independent is reporting. Thirty-four patients taking abacavir had Read more...

ALSO NOTED: Squeaking hip devices worry patients, docs; Biotech M&A has yet to reach its peak;

admin — Mon, 12 May 2008 06:59:50 -0400

> Replacement hips made with ceramic parts are squeaking in certain patients, some of which have sued Stryker; the company says the noisy side effect happens in less than 1 percent of implants. Read more...

GSK accused of monopolizing Wellbutrin

admin — Thu, 08 May 2008 06:59:57 -0400

Did GlaxoSmithKline try to monopolize the Wellbutrin market? A lawsuit now certified as class-action says so. The plaintiffs accuse GSK of artificially boosting Wellbutrin prices by fibbing to the Read more...

Glaxo bonds bring whopping $9B

admin — Wed, 07 May 2008 06:59:54 -0400

GlaxoSmithKline went hat in hand to the bond markets and came back with a record $9 billion. Intending to sell $6 billion in corporate bonds, GSK added $3 billion more as investors hungry for Read more...

GSK shuffles execs in operations overhaul

admin — Thu, 01 May 2008 06:59:58 -0400

If anyone doubted Andrew Witty's (photo) professed faith in Read more...

Pharma CEOs mull industry "trust deficit'

admin — Thu, 24 Apr 2008 06:59:57 -0400

We love it when pharma CEOs depart from their usual talking points about financial results and restructurings and pipelines, to wax philosophical on their place in the word. This week, we heard an Read more...

ALSO NOTED: Novo Nordisk creating 400 NJ jobs; Schering to sell off animal products;

admin — Thu, 24 Apr 2008 06:59:50 -0400

> GlaxoSmithKline is acquiring Cambridge, MA-based Sirtris Pharmaceuticals for $720 million. GSK will pay $22.50 per share for the company. Read more...

GSK, Schering-Plough profits drop

admin — Wed, 23 Apr 2008 06:59:58 -0400

When big drugs tank, they take their makers down with them. Witness first-quarter reports from GlaxoSmithKline and Schering-Plough. GSK is suffering on a Read more...

ALSO NOTED: Bayer sues Watson over Yasmin; Zimmer weeds out doc conflicts

admin — Mon, 21 Apr 2008 06:59:50 -0400

> Open another chapter in the Bayer fight to protect Yasmin patents: Watson Pharmaceuticals filed for FDA approval for its copycat version of the birth control pill, and Bayer sued to keep the Read more...